IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Do myeloma patients who are responding well to their treatment need to track potential bone disease? October 28, 2020 Ask Dr. Durie Isatuximab Plus Carfilzomib and Dexamethasone (ISA-Kd) Vs Kd In RRMM (IKEMA): Interim Analysis of A Phase III, Randomized, Open-Label Study June 16, 2020 ASCO/EHA Analysis of treatment efficacy in the GEM-CESAR trial for high-risk smoldering multiple myeloma patients June 11, 2020 ASCO/EHA Clinical implications of loss of minimal residual disease (MRD) negativity in multiple myeloma June 7, 2020 ASCO/EHA Is it safe for myeloma patients in remission to stop ongoing maintenance therapy? March 26, 2020 Ask Dr. Durie Do fractures resulting from a fall indicate myeloma progression? February 13, 2020 Ask Dr. Durie Can infections, such as Helicobacter pylori, trigger multiple myeloma? February 6, 2020 Ask Dr. Durie Should FISH testing be done at relapse? January 23, 2020 Ask Dr. Durie Should I have an autologous stem cell transplant (ASCT)? December 19, 2019 Ask Dr. Durie La espectrometría de masa Qip en pts con MM de alto riesgo latente incluidos en el ensayo GEM-CESAR December 13, 2019 ASH 4-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone December 13, 2019 ASH Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy December 11, 2019 ASH Load More
